Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Jaya Swarasa Agung Tbk. (TAYS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Jaya Swarasa Agung Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Jaya Swarasa Agung Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 54,95 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TAYS | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 54,95 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Jaya Swarasa Agung Tbk.
PT Jaya Swarasa Agung Tbk (the Company) was established based on Notarial Deed No. 4 dated May 1, 1998 of Trinawati Mulia, S.H., in Jakarta and has received approval as a legal entity from the Minister of Justice and Human Rights of the Republic from Indonesia dated July 19, 1999 through its Decision Letter No.C-13163.01.01.TH.99. The Company started its commercial operation in 1998.
Selengkapnya di halaman TAYS →
